Related Experiment Video
Updated: May 9, 2026
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
New pyrimidine compounds as potent anti-breast cancer agents: synthesis, biological evaluation and computational
Niteen R Sutar1, Shankar G Alegaon1, Shankar Gharge1
1Department of Pharmaceutical Chemistry, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi 591124, Karnataka, India.
Abstract:
Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide, highlighting the urgent need for novel therapeutic agents. In this study, a series of pyrimidine-based derivatives were designed and synthesized to evaluate their potential as anti-breast cancer agents. The compounds were screened for anti-proliferative activity against MDA-MB-231 breast cancer cells, and selected candidates were further assessed for CDK2 inhibitory potential. Among the synthesized compounds, 7b (IC₅₀ = 4.21 ± 0.62 μM) and 7d (IC₅₀ = 5.16 ± 0.71 μM) exhibited potent cytotoxicity and induced apoptosis, with 7d also demonstrating significant CDK2 inhibition. Computational studies, including molecular docking, molecular dynamics simulations, and binding energy analyses, revealed stable interactions within the CDK2 active site. Additionally, ADMET predictions indicated favorable pharmacokinetic and drug-like properties. Overall, these findings suggest that pyrimidine-based compounds, particularly 7b and 7d, possess promising anti-proliferative properties, with CDK2 inhibition contributing to their mechanism of action and supporting their potential as lead candidates for breast cancer therapy.
Insights
New pyrimidine derivatives show promise as breast cancer treatments. Compounds 7b and 7d exhibit potent anti-proliferative effects and induce apoptosis, with compound 7d also inhibiting CDK2, suggesting potential for novel breast cancer therapies.
Area of Science:
- Medicinal Chemistry
- Oncology
- Pharmacology
Background:
- Breast cancer is a leading cause of cancer mortality in women globally.
- There is a critical need for innovative therapeutic strategies.
- Pyrimidine derivatives are explored for their potential anticancer activities.
Purpose of the Study:
- To design and synthesize novel pyrimidine-based compounds.
- To evaluate their anti-proliferative activity against breast cancer cells.
- To assess their potential as CDK2 inhibitors.
Main Methods:
- Synthesis of pyrimidine derivatives.
- Screening for anti-proliferative activity against MDA-MB-231 cells.
- CDK2 inhibition assays.
- Computational studies including molecular docking and dynamics.
- ADMET property predictions.
Main Results:
- Compounds 7b and 7d demonstrated significant cytotoxicity and induced apoptosis in breast cancer cells.
- Compound 7d showed notable CDK2 inhibition.
- Computational analyses confirmed stable binding interactions within the CDK2 active site.
- ADMET predictions suggested favorable pharmacokinetic profiles.
Conclusions:
- Pyrimidine derivatives 7b and 7d exhibit promising anti-breast cancer properties.
- CDK2 inhibition is a potential mechanism of action for these compounds.
- These compounds represent potential lead candidates for future breast cancer drug development.